AP3415A - Method for manufacturing of naltrexone - Google Patents

Method for manufacturing of naltrexone

Info

Publication number
AP3415A
AP3415A AP2013006897A AP2013006897A AP3415A AP 3415 A AP3415 A AP 3415A AP 2013006897 A AP2013006897 A AP 2013006897A AP 2013006897 A AP2013006897 A AP 2013006897A AP 3415 A AP3415 A AP 3415A
Authority
AP
ARIPO
Prior art keywords
naltrexone
manufacturing
Prior art date
Application number
AP2013006897A
Other languages
English (en)
Other versions
AP2013006897A0 (en
Inventor
Mariano Stivanello
Carla De Faveri
Florian Anton Martin Huber
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of AP2013006897A0 publication Critical patent/AP2013006897A0/xx
Application granted granted Critical
Publication of AP3415A publication Critical patent/AP3415A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08Oxygen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AP2013006897A 2010-11-05 2011-11-04 Method for manufacturing of naltrexone AP3415A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US41040510P 2010-11-05 2010-11-05
DKPA201001007 2010-11-05
US201161489701P 2011-05-25 2011-05-25
DKPA201100396 2011-05-25
PCT/DK2011/000128 WO2012059103A1 (en) 2010-11-05 2011-11-04 Method for the manufacturing of naltrexone

Publications (2)

Publication Number Publication Date
AP2013006897A0 AP2013006897A0 (en) 2013-05-31
AP3415A true AP3415A (en) 2015-09-30

Family

ID=45001588

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2013006897A AP3415A (en) 2010-11-05 2011-11-04 Method for manufacturing of naltrexone

Country Status (20)

Country Link
EP (1) EP2635586B1 (enExample)
JP (2) JP6246589B2 (enExample)
AP (1) AP3415A (enExample)
AU (1) AU2011325563B2 (enExample)
CA (1) CA2815093C (enExample)
CY (1) CY1118742T1 (enExample)
DK (1) DK2635586T3 (enExample)
EA (1) EA022266B1 (enExample)
ES (1) ES2620660T3 (enExample)
HR (1) HRP20170379T1 (enExample)
HU (1) HUE033596T2 (enExample)
LT (1) LT2635586T (enExample)
ME (1) ME02621B (enExample)
MX (1) MX2013005009A (enExample)
PL (1) PL2635586T3 (enExample)
PT (1) PT2635586T (enExample)
RS (1) RS55777B1 (enExample)
SI (1) SI2635586T1 (enExample)
SM (1) SMT201700177T1 (enExample)
WO (1) WO2012059103A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140005217A1 (en) 2012-06-27 2014-01-02 H. Lundbeck A/S Nalmefene for reduction of alcohol consumption in specific target populations
AR096851A1 (es) 2013-07-11 2016-02-03 H Lundbeck As Sales que no forman hidratos ni solvatos de nalmefeno
AU2014368548B2 (en) 2013-12-20 2019-09-19 H. Lundbeck A/S Use of an opioid receptor antagonist with kappa-activity and vortioxetine for treatment of depressive disorder with melancholic features
MX2016013889A (es) 2014-04-22 2017-03-09 Otsuka Pharma Co Ltd Medicamento.
US9701688B2 (en) * 2014-05-05 2017-07-11 Noramco, Inc. Process for the preparation of opioid compounds
US9701687B2 (en) * 2014-05-05 2017-07-11 Noramco, Inc. Process for the preparation of opioid compounds

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991005768A1 (en) * 1989-10-16 1991-05-02 The United States Of America, Represented By The Secretary, United States Department Of Commerce Total synthesis of northebaine, normorphine, noroxymorphone enantiomers and derivatives via n-nor intermediates
WO2010039209A2 (en) * 2008-09-30 2010-04-08 Mallinckrodt Inc. Processes for the synthesis of tertiary amines

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4535157A (en) 1983-11-01 1985-08-13 Key Pharmaceuticals, Inc. Process for making 6-desoxy-6-methylenenaloxone and 6-desoxy-6-methylenenaltrexone
US4751307A (en) 1985-01-17 1988-06-14 Mallinckrodt, Inc. Wittig-reaction processes
FR2906252B1 (fr) 2006-09-21 2008-11-28 Sanofi Aventis Sa Procede de preparation d'halogenures de n-aklyl naltrexone
WO2008138383A1 (de) 2007-05-16 2008-11-20 Cilag Ag Verfahren zur herstellung von n-methylnaltrexonbromid
JP5794980B2 (ja) 2009-05-25 2015-10-14 ハー・ルンドベック・アクチエゼルスカベット ナルトレキソンからの塩酸ナルメフェンの調製

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991005768A1 (en) * 1989-10-16 1991-05-02 The United States Of America, Represented By The Secretary, United States Department Of Commerce Total synthesis of northebaine, normorphine, noroxymorphone enantiomers and derivatives via n-nor intermediates
WO2010039209A2 (en) * 2008-09-30 2010-04-08 Mallinckrodt Inc. Processes for the synthesis of tertiary amines

Also Published As

Publication number Publication date
CY1118742T1 (el) 2017-07-12
AU2011325563A1 (en) 2013-05-02
DK2635586T3 (en) 2017-03-27
JP2016199566A (ja) 2016-12-01
ME02621B (me) 2017-06-20
EP2635586B1 (en) 2017-02-08
JP6246589B2 (ja) 2017-12-13
SMT201700177T1 (it) 2017-05-08
MX2013005009A (es) 2013-08-01
RS55777B1 (sr) 2017-07-31
ES2620660T3 (es) 2017-06-29
AU2011325563B2 (en) 2015-08-20
HUE033596T2 (hu) 2017-12-28
PL2635586T3 (pl) 2017-06-30
EP2635586A1 (en) 2013-09-11
HRP20170379T1 (hr) 2017-05-05
JP2013541564A (ja) 2013-11-14
JP6215399B2 (ja) 2017-10-18
AP2013006897A0 (en) 2013-05-31
SI2635586T1 (sl) 2017-07-31
LT2635586T (lt) 2017-04-10
EA022266B1 (ru) 2015-11-30
EA201390658A1 (ru) 2013-11-29
WO2012059103A1 (en) 2012-05-10
CA2815093C (en) 2019-08-06
CA2815093A1 (en) 2012-05-10
PT2635586T (pt) 2017-03-30

Similar Documents

Publication Publication Date Title
IL248217B (en) A method for the production of inganol-3-englate
PL2612859T3 (pl) Sposób wytwarzania pochodnej 1-triazolo-2-butanolu
ZA201209370B (en) Method for manufacturing of quinoline-3-carboxamides
GB201016436D0 (en) Method of making solid beads
EP2616881A4 (en) STRUCTURE FORMING PROCESS
PT2853609T (pt) Método de fabrico de um componente estrutural de um veículo
GB2485831B (en) A method of manufacturing a component
EP2610338A4 (en) PROCESS FOR PRODUCTION OF SUBSTANCE
IL226131A0 (en) A method for creating an insulated structure
AP3415A (en) Method for manufacturing of naltrexone
EP2653482A4 (en) PROCESS FOR PRODUCING PSEUDOPOLYROTAXANE
GB201008900D0 (en) Method of machining
EP2557903A4 (en) METHOD FOR PRODUCING AN EXTERNAL LEADER
GB201007454D0 (en) Method of determining tolerance
PL2476684T3 (pl) Sposób wytwarzania alkilofosforanów
EP2581191A4 (en) CHIP PROCESS
GB201006348D0 (en) Method of manufacturing a component
PL2571887T3 (pl) Sposoby wytwarzania ditiino-tetrakarboksy-diimidów
PL2547683T3 (pl) Sposób wytwarzania Sitagliptyny
PL2476685T3 (pl) Sposób wytwarzania alkilofosforanów
EP2586774A4 (en) PROCESS FOR THE PREPARATION OF RANOLAZINE
GB201119607D0 (en) Method of manufacture
PL2476686T3 (pl) Sposób wytwarzania alkilofosforanów
GB201020521D0 (en) Method of making patterns
ZA201303224B (en) Method for the manufacturing of naltrexone